According to a statement by the Health Canada, it may issue a recall if the imported Maggi brand noodles are found to have discrepancies.
Read more from our special coverage on "NESTLE MAGGI CONTROVERSY"
“The CFIA is aware of the recent incident in India involving Maggi brand noodles, including Nestlé’s removal of products from the Indian marketplace. “The CFIA is conducting a food safety investigation for the possible presence of lead in Maggi brand noodle products imported into Canada by various firms. If affected products are identified as part of the agency’s ongoing investigation, a food recall warning will be issued,” the Canadian health regulator said.
The CFIA takes food safety concerns very seriously. More information will be shared with the public as it becomes available, it added. Nestlé India currently exports small quantities of Maggi noodles to the US, Canada, UK, Australia, Singapore and Kenya.
Reacting to the development, Nestlé said in a statement, “We are working closely with the regulators in each country to explain the situation in India and, where they want to test the products, we are cooperating fully with them.”
“We also manufacture Maggi noodles in other countries and these are not affected by the situation in India." Unfortunately, recent developments and unfounded concerns about the product in India have led to an environment of confusion for the consumer there, to such an extent that Nestlé India has decided to withdraw the product off the shelves in India, the company said. “The batch of Maggi Noodles in question is not distributed by Nestle Canada, in fact, the Canadian product has its own custom recipe and packaging.”
“We assure consumers that all Maggi products in Canada are safe to consume,” it added.
In India, several states including Delhi, Uttarakhand, Jammu and Kashmir, Punjab, Gujarat, Madhya Pradesh, Maharashtra and Goa have banned sale of Maggi noodles.
Cracking down on Swiss giant Nestle, central health regulator FSSAI on Friday banned all variants of Maggi noodles terming them as "unsafe and hazardous" for human consumption.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app